Frontlight ResearchEarly access
Not yet taking people in DenmarkPhase 1
Testing oxygen with antibiotics for chronic lung infection in people with cystic fibrosis
Tests whether added oxygen helps antibiotics treat a long-lasting lung infection in adults.
Key facts
- Who runs it
- Rigshospitalet
- Where
- Copenhagen Oe, DenmarkSee the site
- Trial code
- EU 2024-513197-22-02
- U1111-1303-6004
- Registry title
- Adding oxygen to enhance antibiotic treatment of chronic lung infection
- Status
- Not yet recruiting
- Phase
- Phase 1
- People taking part
- 10 people, planned
- Started
- 8 Aug 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Record updated
- 13 September 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with primary ciliary dyskinesia or cystic fibrosis who have a long-lasting Pseudomonas aeruginosa lung infection.
- Age
- 18 years or older
- Sex
- All sexes can join
Where in Denmark
- RigshospitaletCopenhagen Oe, DenmarkNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Testing oxygen with antibiotics for chronic lung infection in people with cystic fibrosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 13 September 2024